Taken together, our findings indicate that the absence of Sema3E confers protection against BLM‐induced lung fibrosis in mice, highlighting the potential therapeutic significance of targeting Sema3E in the treatment of pulmonary fibrosis. This evidence concerns the gene SEMA3E and pulmonary fibrosis.